Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Shu

Showing results (91-100 of 113) with videos related to

Pageof 12
Sort By:
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|May 25, 2026
Cigarette smoking drives earlier development of pancreatic adenocarcinoma among carriers of hereditary pancreatic cancer susceptibility genesTimothy D Shu, Lynette M Smith, Erik Gunnarsson, et al.
Optics Express|February 12, 2014
Hybrid diamond-silicon angular-dispersive x-ray monochromator with 0.25-meV energy bandwidth and high spectral efficiencyS Stoupin, Y V Shvyd'ko, D Shu, et al.
European Journal of Endocrinology|May 18, 2026
Navepegritide Combined with Lonapegsomatropin for the Treatment of Children with Achondroplasia: 52-Week Results from the Phase 2 COACH TrialCiara M McDonnell, Melita Irving, Line Aagaard Nolting, et al.
Vaccine|January 12, 2011
A nasally administered trivalent inactivated influenza vaccine is well tolerated, stimulates both mucosal and systemic immunity, and potentially protects against influenza illnessJ M Langley, F Aoki, B J Ward, et al.
The Journal of Clinical Endocrinology and Metabolism|December 16, 2021
Response to Letter to the Editor From Malozowski: "Weekly Lonapegsomatropin in Treatment-Naïve Children With Growth Hormone Deficiency: The Phase 3 heiGHt Trial"Paul S Thornton, Aristides K Maniatis, Elena Aghajanova, et al.
Journal of X-Ray Science and Technology|February 11, 2011
Coherent Radiation for X-Ray Imaging-The Soft X-Ray Undulator and the X1A Beamline at the NSLSH Rarback, C Buckley, H Ade, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|February 4, 2026
Palopegteriparatide for Adults with Chronic Hypoparathyroidism: Skeletal Dynamics Through 3 yr of the Phase 2 paTH Forward TrialMishaela R Rubin, Bart L Clarke, Lorenz C Hofbauer, et al.
The Journal of Clinical Endocrinology and Metabolism|December 9, 2025
Patient-Reported Outcomes in Palopegteriparatide-Treated Adults with Hypoparathyroidism: PaTH Forward Trial ExtensionMishaela Rubin, Andrea Palermo, Tamara Vokes, et al.
Hormone Research in Paediatrics|March 9, 2022
Switching to Weekly Lonapegsomatropin from Daily Somatropin in Children with Growth Hormone Deficiency: The fliGHt TrialAristides K Maniatis, Ulhas Nadgir, Paul Saenger, et al.
The Journal of Clinical Endocrinology and Metabolism|July 17, 2021
Weekly Lonapegsomatropin in Treatment-Naïve Children With Growth Hormone Deficiency: The Phase 3 heiGHt TrialPaul S Thornton, Aristides K Maniatis, Elena Aghajanova, et al.
Pageof 12

Showing results (91-100 of 113) with videos related to

Sort By:
Pageof 12
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|May 25, 2026
Cigarette smoking drives earlier development of pancreatic adenocarcinoma among carriers of hereditary pancreatic cancer susceptibility genesTimothy D Shu, Lynette M Smith, Erik Gunnarsson, et al.
Optics Express|February 12, 2014
Hybrid diamond-silicon angular-dispersive x-ray monochromator with 0.25-meV energy bandwidth and high spectral efficiencyS Stoupin, Y V Shvyd'ko, D Shu, et al.
European Journal of Endocrinology|May 18, 2026
Navepegritide Combined with Lonapegsomatropin for the Treatment of Children with Achondroplasia: 52-Week Results from the Phase 2 COACH TrialCiara M McDonnell, Melita Irving, Line Aagaard Nolting, et al.
Vaccine|January 12, 2011
A nasally administered trivalent inactivated influenza vaccine is well tolerated, stimulates both mucosal and systemic immunity, and potentially protects against influenza illnessJ M Langley, F Aoki, B J Ward, et al.
The Journal of Clinical Endocrinology and Metabolism|December 16, 2021
Response to Letter to the Editor From Malozowski: "Weekly Lonapegsomatropin in Treatment-Naïve Children With Growth Hormone Deficiency: The Phase 3 heiGHt Trial"Paul S Thornton, Aristides K Maniatis, Elena Aghajanova, et al.
Journal of X-Ray Science and Technology|February 11, 2011
Coherent Radiation for X-Ray Imaging-The Soft X-Ray Undulator and the X1A Beamline at the NSLSH Rarback, C Buckley, H Ade, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|February 4, 2026
Palopegteriparatide for Adults with Chronic Hypoparathyroidism: Skeletal Dynamics Through 3 yr of the Phase 2 paTH Forward TrialMishaela R Rubin, Bart L Clarke, Lorenz C Hofbauer, et al.
The Journal of Clinical Endocrinology and Metabolism|December 9, 2025
Patient-Reported Outcomes in Palopegteriparatide-Treated Adults with Hypoparathyroidism: PaTH Forward Trial ExtensionMishaela Rubin, Andrea Palermo, Tamara Vokes, et al.
Hormone Research in Paediatrics|March 9, 2022
Switching to Weekly Lonapegsomatropin from Daily Somatropin in Children with Growth Hormone Deficiency: The fliGHt TrialAristides K Maniatis, Ulhas Nadgir, Paul Saenger, et al.
The Journal of Clinical Endocrinology and Metabolism|July 17, 2021
Weekly Lonapegsomatropin in Treatment-Naïve Children With Growth Hormone Deficiency: The Phase 3 heiGHt TrialPaul S Thornton, Aristides K Maniatis, Elena Aghajanova, et al.
Pageof 12